Dana-Farber/Mass General Brigham Cancer Care

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Adoptive Cellular Immunotherapy, Cell Therapy, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Mycosis Fungoides

Studies at this site

• A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL — Paused